Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-22-028045
Filing Date
2022-02-28
Accepted
2022-02-28 16:02:00
Documents
9
Effectiveness Date
2022-02-28

Document Format Files

Seq Description Document Type Size
1 POSASR tm227825d1_posasr.htm POSASR 444314
2 EXHIBIT 5.1 tm227825d1_ex5-1.htm EX-5.1 40845
3 EXHIBIT 23.1 tm227825d1_ex23-1.htm EX-23.1 2172
4 EXHIBIT 24.2 tm227825d1_ex24-2.htm EX-24.2 3920
5 EX-FILING FEES tm227825d1_ex-fillingfees.htm EX-FILING FEES 54860
6 GRAPHIC tm227825d1_posasrs1img001.jpg GRAPHIC 4290
7 GRAPHIC tm227825d1_posasrsp3img001.jpg GRAPHIC 4259
8 GRAPHIC tm227825d1_ex5-1img001.jpg GRAPHIC 2238
9 GRAPHIC tm227825d1_ex5-1img002.jpg GRAPHIC 31408
  Complete submission text file 0001104659-22-028045.txt   605951
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-251327 | Film No.: 22689221
SIC: 2834 Pharmaceutical Preparations